MedPath

Instanyl

Instanyl Fentanyl Nasal Spray

Approved
Approval ID

92c19d5a-0fe2-777d-e053-2995a90a4f3f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 3, 2023

Manufacturers
FDA

Renaissance Lakewood LLC

DUNS: 077744035

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fentanyl Nasal Spray

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code49396-0512
Product Classification
G
Generic Name
Fentanyl Nasal Spray
Product Specifications
Route of AdministrationNASAL
Effective DateMarch 3, 2023
FDA Product Classification

INGREDIENTS (4)

WATERInactive
Code: 059QF0KO0R
Classification: IACT
FENTANYL CITRATEActive
Quantity: 2 mg in 1 mL
Code: MUN5LYG46H
Classification: ACTIM
SODIUM PHOSPHATE, DIBASICInactive
Code: GR686LBA74
Classification: IACT
SODIUM PHOSPHATE, MONOBASICInactive
Code: 3980JIH2SW
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Instanyl - FDA Drug Approval Details